Stephanie Lodise a Speaker for Panel on "GSK v. Teva" Ruling

News / November 2, 2020

Partner Stephanie Lodise will be a speaker for an IPO IP Chat Channel webinar titled “Skinny Labels and Inducing Infringement After GSK v. Teva,” on Nov. 5, 2020. The webinar presenters will discuss the precedential decision, which has potentially far-reaching impacts in Hatch-Waxman and biosimilar litigation, research agendas and patent prosecution.

More information.